Viking Therapeutics jumped by 9.74 percent on Tuesday to close at $30.19 apiece as investors repositioned portfolios ahead of the expected release of the results of its own weight...
Keep Reading →
July 9 - News
We recently published a list of Investors Are Gobbling Up Shares of These 10 Firms.
Keep Reading →
June 12 - News
We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at where Viking Therapeutics, Inc.
Keep Reading →
June 9 - News
During a recent episode of Mad Money, Jim Cramer discussed how the recent wave of deregulation by the U.S.
Keep Reading →
June 8 - Hedge Funds, News
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
Keep Reading →
April 23 - Hedge Funds, Market Movers, News
Market analysts are increasingly highlighting mid-cap stocks as a potentially attractive investment opportunity, particularly in the current economic climate.
Keep Reading →
February 26 - Hedge Funds, News
We came across a bullish thesis on Viking Therapeutics, Inc. (VKTX) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on VKTX.
Keep Reading →
February 26 - News, Stock Analysis
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
Keep Reading →
February 24 - Hedge Funds, News
Historically, the S&P 500's performance in January sets the pace for the rest of the year.
Keep Reading →
February 4 - Hedge Funds, News
Jim Cramer, the host of Mad Money, recently revisited one of his core investment principles: "Nobody ever made a dime panicking." He emphasized that, no matter how many times ...
Keep Reading →
January 31 - Hedge Funds, News
Jim Cramer, the host of Mad Money, recently expressed his concerns about the uncertain economic outlook for 2025, particularly in relation to corporate earnings and the stock ...
Keep Reading →
January 31 - Hedge Funds, News
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
Keep Reading →
January 17 - Hedge Funds, News
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
Keep Reading →
December 31 - Hedge Funds, News
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
Keep Reading →
December 24 - Hedge Funds, News
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Keep Reading →
December 23 - Hedge Funds, News
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Keep Reading →
December 14 - Hedge Funds, News
Paul Hickey, Bespoke co-founder, together with Dana D'Auria, Envestnet co-chief Investment Officer, joined CNBC's 'Closing Bell: Overtime' on November 12 to discuss the market...
Keep Reading →
November 21 - Hedge Funds, News
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2024 Earnings Call Transcript October 23, 2024Viking Therapeutics, Inc. beats earnings expectations.
Keep Reading →
October 24 - News, Transcripts
While the market is seeing significant positives after the Fed rate cut, there have been some pressures.
Keep Reading →
October 3 - Hedge Funds, News
After the latest 50 basis point rate cut by the Federal Reserve, the market has been performing well.
Keep Reading →
September 25 - Hedge Funds, News
The recent Fed rate cut has made the market cautiously optimistic. Despite the unusual timing, historical data suggests a continued upward trend.
Keep Reading →
September 25 - Hedge Funds, News
September has historically been one of the worst months for US stocks.
Keep Reading →
September 14 - Hedge Funds, News
Fred Alger Management, an investment management company, released its “Alger Mid Cap Focus Fund” second quarter 2024 investor letter.
Keep Reading →
September 4 - Hedge Fund Investor Letters, News
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter.
Keep Reading →
August 29 - Hedge Fund Investor Letters, News
The tail end of August is appearing to turn a fresh page for Wall Street.
Keep Reading →
August 26 - Market Movers, News
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
August 2 - Hedge Fund Investor Letters, News
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2024 Earnings Call Transcript July 24, 2024Viking Therapeutics, Inc. beats earnings expectations.
Keep Reading →
July 25 - News, Transcripts
This article looks at the 10 best healthcare stocks to buy under $50.
Keep Reading →
June 26 - News
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Growth—U.S. Strategy” first-quarter 2024 investor letter.
Keep Reading →
June 18 - Hedge Fund Investor Letters, News
Baron Funds, an investment management company, released its “Baron Opportunity Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
June 11 - Hedge Fund Investor Letters, News
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded...
Keep Reading →
June 7 - Hedge Fund Investor Letters, News
Jim Cramer in a latest program said the "bulls" want the economy to slow down, they want rate cuts as well as a strong demand so that "their companies" won't have to worry about...
Keep Reading →
June 5 - Hedge Funds, News
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter 2024 investor letter.
Keep Reading →
May 31 - Hedge Fund Investor Letters, News
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we will look at a particular biotech which recently got a "Strong Buy" rating...
Keep Reading →
May 27 - Hedge Funds, News
The healthcare industry is considered to be a fairly defensive sector due to its need.
Keep Reading →
May 27 - Hedge Funds, News
Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc.
Keep Reading →
April 26 - News, Transcripts
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter.
Keep Reading →
April 10 - Hedge Fund Investor Letters, News
In this piece, we will take a look at the ten best weight loss drug stocks to buy now.
Keep Reading →
April 6 - Hedge Funds, News
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
In this article, we will take a detailed look at the 13 Best Booming Stocks to Buy Right Now. For a quick overview of such stocks, read our article 5 Best Booming Stocks to...
Keep Reading →
February 21 - Hedge Funds, News
Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
February 8 - News, Transcripts
Operator: Welcome to the Viking Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
October 27 - News, Transcripts
In this piece, we will take a look at the 15 most shorted stocks that are loved by analysts.
Keep Reading →
August 28 - News
In this article, we will be taking a look at the 5 best weight loss stocks to invest in.
Keep Reading →
August 22 - Hedge Funds, News
In this article, we will take a look at the 15 best-performing stocks in the last 12 months.
Keep Reading →
August 17 - Hedge Funds, Market Movers, News
In this article, we will take a look at the 10 oversold biotech stocks to buy.
Keep Reading →
July 29 - Hedge Funds, Lists, Market Movers
Operator: Welcome to the Viking Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
July 28 - News, Transcripts
In this piece, we will take a look at ten stocks that Wall Street analysts and billionaires are crazy about.
Keep Reading →
June 7 - Hedge Funds, News
Operator: Welcome to the Viking Therapeutics First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
May 4 - News, Transcripts
Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full-year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
February 11 - News, Transcripts
